EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system



Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system



Journal of Pharmaceutical Sciences 93(5): 1165-1175



Different formulation approaches were evaluated to ensure that the formulation of a poorly water soluble compound chosen during early development achieves optimum bioavailability. The insoluble compound has an aqueous solubility of 0.17 mug/mL at 25 +/- 1degreeC, a relatively high permeability (Caco2 Papp = 6.1 x 10-4 cm/min), and poor bioavailability in dogs (dry blend formulation). Based on the prediction by GastroPlus(TM), the oral absorption of this compound is sensitive to its apparent solubility and particle size. The oral bioavailability of three different formulations was compared in a dog model: a cosolvent-surfactant solution, a solid dispersion in a mixture of polyethylene glycol 3350 and polysorbate 80, and a dry blend of micronized drug with microcrystalline cellulose. In absence of a parenteral injection, the bioavailability of the solution was considered to be 100%, and the relative oral bioavailability of the three formulations was 100, 99.1, 9.8, respectively. Comparable bioavailability was obtained with the solid dispersion and the cosolvent-surfactant solution, both of which showed a 10-fold higher bioavailability than the dry blend. Thus, a 20 mg dose strength capsule containing the solid dispersion formulation was selected for clinical development. The selected solid dispersion system was physically and chemically stable for at least 16 months at 25degreeC/60% RH. In conclusion, the bioavailability of a poorly water soluble drug was greatly enhanced using the solid dispersion formulation containing a water soluble polymer with a surface active agent. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association.

(PDF emailed within 0-6 h: $19.90)

Accession: 011945969

Download citation: RISBibTeXText

PMID: 15067693

DOI: 10.1002/jps.20044



Related references

Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. International Journal of Pharmaceutics 269(1): 251-258, 2003

Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. Journal of Pharmaceutical Sciences 98(5): 1750-1764, 2008

Improved dissolution of a poorly water-soluble drug from solid dispersions in polyethylene glycol: polysorbate 80 mixtures. Journal of Pharmaceutical Sciences 79(5): 463-464, 1990

Comparative evaluation of polyethylene glycol 4000 and poloxamer as solid dispersion systems for a poorly water soluble antidiabetic drug. Pharmaceutical Research (New York) 8(10 SUPPL): S89, 1991

Improving the dissolution and oral bioavailability of the poorly water-soluble drug aloe-emodin by solid dispersion with polyethylene glycol 6000. Drug Development Research 70(5): 363-369, 2009

Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug. Drug Delivery and Translational Research 6(5): 540-550, 2016

Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Molecular Pharmaceutics 5(6): 994-1002, 2009

Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. International Journal of Pharmaceutical Investigation 7(3): 142-148, 2017

Erratum: Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. International Journal of Pharmaceutical Investigation 7(4): 198-198, 2018

Application of Abelmoschus esculentus in solid dosage formulation 1: Use as a binder for a poorly water soluble drug. Indian Journal of Pharmaceutical Sciences 63(3): 234-238, May-June, 2001

Improvement of bioavailability of poorly water-soluble drug by nanoparticles from a solid dispersion system. Yakuzaigaku 57(2): 95-101, June, 1997

Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364. International Journal of Pharmaceutics 452(1-2): 73-81, 2014

Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. Journal of Pharmaceutical Sciences 81(12): 1185-1188, 1992

Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. International Journal of Pharmaceutics 302(1-2): 95-102, 2005

Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram. International Journal of Pharmaceutics 497(1-2): 3-11, 2016